-
EP4329817
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4329817
| EP4329817 - DOSING REGIMENS OF PEPTIDE CONJUGATES OF TOPOISOMERASE I INHIBITORS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.02.2024 Database last updated on 14.11.2024 | |
| Former | The international publication has been made Status updated on 04.11.2022 | ||
| Former | unknown Status updated on 30.05.2022 | Most recent event Tooltip | 06.06.2024 | Amendment by applicant | Applicant(s) | For all designated states Cybrexa 2, Inc. 5 Science Park 395 Winchester Avenue New Haven, Connecticut 06511 / US | [2024/10] | Inventor(s) | 01 /
PARALKAR, Vishwas New Haven, Connecticut 06511 / US | 02 /
DECILLIS, Arthur P. New Haven, Connecticut 06511 / US | [2024/10] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2024/10] | Application number, filing date | 22724607.1 | 28.04.2022 | [2024/10] | WO2022US71967 | Priority number, date | US202163181640P | 29.04.2021 Original published format: US 202163181640 P | [2024/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022232808 | Date: | 03.11.2022 | Language: | EN | [2022/44] | Type: | A1 Application with search report | No.: | EP4329817 | Date: | 06.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.11.2022 takes the place of the publication of the European patent application. | [2024/10] | Search report(s) | International search report - published on: | EP | 03.11.2022 | Classification | IPC: | A61K47/64, A61P35/00 | [2024/10] | CPC: |
A61K47/64 (EP,IL,KR,US);
A61K31/4745 (KR);
A61K45/06 (EP,IL);
A61K9/0019 (US);
A61P35/00 (EP,IL,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/10] | Extension states | BA | 27.10.2023 | ME | 27.10.2023 | Validation states | KH | 27.10.2023 | MA | 27.10.2023 | MD | 27.10.2023 | TN | 27.10.2023 | Title | German: | DOSIERUNGSSCHEMATA VON PEPTIDKONJUGATEN VON TOPOISOMERASE-I-INHIBITOREN | [2024/10] | English: | DOSING REGIMENS OF PEPTIDE CONJUGATES OF TOPOISOMERASE I INHIBITORS | [2024/10] | French: | SCHÉMAS POSOLOGIQUES DE CONJUGUÉS PEPTIDIQUES D'INHIBITEURS DE LA TOPOISOMÉRASE I | [2024/10] | Entry into regional phase | 27.10.2023 | National basic fee paid | 27.10.2023 | Designation fee(s) paid | 27.10.2023 | Examination fee paid | Examination procedure | 27.10.2023 | Examination requested [2024/10] | 27.10.2023 | Date on which the examining division has become responsible | 06.06.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IY]US2021009719 (MARSHALL DANIEL RICHARD [US], et al); | by applicant | US8076451 | US9289508 | US2019209580 | US2021009719 |